← SynDRA

ICOSAPENT

SynDRA canonical compound SYN0011254 — structure-anchored drug synonym record

Clinical phaseLaunched
Approval statusApproved · Rx/OTC
Primary target(s)ACSL3 | ACSL4 | FADS1 | FFAR1 | PPARD | PPARG | PTGS1 | PTGS2 | SLC8A1 | TRPV1
Mechanism of actionplatelet aggregation inhibitor
Indicationhypertriglyceridemia
Disease areaendocrinology

All known targets

Mechanisms of action (all sources)

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

Drug classes

Cross-references

Synonyms

Reported adverse events

Look up ICOSAPENT in the interactive SynDRA portal →